文献速递系统性红斑狼疮其他结缔组织病血管炎

晚期心血管影像在风湿免疫介导炎症性疾病中的应用

Use of advanced cardiovascular imaging in rheumatic immune-mediated inflammatory diseases.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

结果显示59.5%的检查发现心血管异常,且多数异常见于无症状患者;影像促使31.3%患者调整IMID治疗,但仅23.1%经正式MDT讨论。

要点

  • 晚期心血管影像在风湿免疫介导炎症性疾病中常发现心血管受累,包括无症状患者。
  • 影像结果促使31.3%患者调整IMID治疗,但仅23.1%经正式MDT讨论。
  • 需建立心脏-风湿病MDT以支持整合决策并改善患者结局。

核心结论

  • 晚期心血管影像在风湿免疫介导炎症性疾病中频繁发现心血管受累,包括无症状患者。
  • 影像结果促使约三分之一患者调整IMID治疗,但多数调整在正式MDT流程之外进行。

研究设计与样本

  • 回顾性、多中心质量改进项目,覆盖英国四家大型医院。
  • 共纳入261例患者的294次影像检查,其中女性占72.4%,65.9%年龄在40-74岁。

主要发现

  • 294次检查包括137次(46.6%)CMR、40次(13.6%)CTCA和117次(39.8%)PET。
  • 175/294次(59.5%)检查报告心血管异常,血管炎中最常见(53.7%)。
  • 异常PET中54/63次(85.7%)和异常CMR中61/89次(68.5%)见于无症状患者。
  • 影像发现促使59.5%转诊心脏科或持续随访,31.3%调整IMID治疗,仅23.1%经正式MDT讨论。

临床怎么用

  • 对风湿免疫介导炎症性疾病患者应考虑晚期心血管影像以识别无症状心血管受累。
  • 影像发现应纳入心脏-风湿病MDT讨论以支持整合治疗决策。

局限性

  • 回顾性设计且仅纳入英国四家医院,可能存在选择偏倚和中心间实践差异。
  • 样本以常见亚型为主,对罕见风湿免疫介导炎症性疾病的代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the real-world use of advanced cardiovascular imaging in less common and rare rheumatic immune-mediated inflammatory diseases (IMIDs) and identify variation in practice to inform future studies and clinical guidelines. METHODS: A retrospective, multicentre quality improvement project was conducted across four major hospitals in the UK. Adults with SLE, SSc, idiopathic inflammatory myopathy, vasculitis or SS who underwent cardiovascular magnetic resonance (CMR), CT coronary angiography (CTCA) or PET between January 2023 and December 2024 were included. Demographics, IMID characteristics, cardiovascular risk factors, imaging indications, findings and management were extracted using a standardized proforma and analysed. RESULTS: A total of 294 imaging studies were performed in 261 patients (72.4% female, 65.9% aged 40-74 years) comprising 137 (46.6%) CMR, 40 (13.6%) CTCA and 117 (39.8%) PET scans. Indications varied by modality and centre. Cardiovascular abnormalities were reported in 175/294 (59.5%), most commonly in vasculitis (53.7%). Notably, 54/63 (85.7%) of abnormal PET and 61/89 (68.5%) of abnormal CMR scans were in asymptomatic patients. Imaging findings prompted cardiology referral/ongoing follow-up in 59.5% and changes to IMID treatment in 31.3%, but only 23.1% were discussed in a formal multidisciplinary team (MDT). CONCLUSION: Advanced cardiovascular imaging frequently identifies cardiovascular involvement in rheumatic IMIDs, including in asymptomatic patients. Treatment adjustments occurred in a third of patients, although largely undertaken outside established MDT processes. These findings emphasize the need for better understanding of imaging-based findings and for cardio-rheumatology MDTs to support integrated decision-making to improve patient outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Gumber L, Meghji MA, Kakkar V, et al. Use of advanced cardiovascular imaging in rheumatic immune-mediated inflammatory diseases. Rheumatology (Oxford). 2026. PMID: 42384193. doi:10.1093/rheumatology/keag347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。